Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-03-31): 13.66%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
-311.30%
NET PROFIT MARGIN AVG 3Y
-99.23%
NET PROFIT MARGIN AVG 5Y
-174.89%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
China SXT Pharmaceuticals, Inc.
Market Cap
$667469.00
Net Profit Margin
N/A
TTM Avg
-311.30%
3Y Avg
-99.23%
5Y Avg
-174.89%
Market Cap
$716854.00
Net Profit Margin
6.30%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$545796.00
Net Profit Margin
-73.22%
TTM Avg
-7923.42%
3Y Avg
-4237.01%
5Y Avg
-2848.17%
Market Cap
$518606.00
Net Profit Margin
-11016.07%
TTM Avg
-6147.48%
3Y Avg
-7604.80%
5Y Avg
-5197.06%
Market Cap
$824550.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-23.42%
Market Cap
$835994.00
Net Profit Margin
N/A
TTM Avg
3.77%
3Y Avg
-2.35%
5Y Avg
-2.90%
Market Cap
$838843.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-933.28%
5Y Avg
-622.19%
Market Cap
$481786.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$868077.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals, Inc. (SXTC) | $667469.00 | N/A | -311.30% | -99.23% | -174.89% |
| CDT Equity Inc. (CDT)vs › | $716854.00 | 6.30% | 0.00% | 0.00% | 0.00% |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -73.22% | -7923.42% | -4237.01% | -2848.17% |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | -11016.07% | -6147.48% | -7604.80% | -5197.06% |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | 0.00% | 0.00% | 0.00% | -23.42% |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A | 3.77% | -2.35% | -2.90% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838843.00 | 0.00% | 0.00% | -933.28% | -622.19% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $868077.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 13.66% |
| 2025-12-31 | 32.01% |
| 2025-09-30 | -1016.46% |
| 2025-03-31 | -274.42% |
| 2024-12-31 | -274.42% |
| 2024-09-30 | -96.75% |
| 2024-06-30 | -96.75% |
| 2024-03-31 | 75.33% |
| 2023-12-31 | 439.21% |
| 2023-09-30 | -539.78% |
| 2023-06-30 | -1031.97% |
| 2023-03-31 | -270.43% |
| 2022-12-31 | -581.64% |
| 2022-09-30 | -123.70% |
| 2022-06-30 | -123.70% |
| 2022-03-31 | -58.87% |
| 2021-12-31 | -167.93% |
| 2021-09-30 | -125.00% |
| 2021-06-30 | -300.86% |
| 2021-03-31 | -59.84% |
| 2020-12-31 | -96.53% |
| 2020-09-30 | 35.78% |
| 2020-06-30 | 35.78% |
| 2020-03-31 | -1056.73% |
| 2019-12-31 | -407.77% |
| 2019-09-30 | -73.03% |
| 2019-06-30 | -73.03% |
| 2019-03-31 | 99.49% |
| 2018-12-31 | 17.59% |
| 2018-09-30 | 50.80% |
| 2018-06-30 | 25.40% |
| 2018-03-31 | 12.69% |
| 2017-12-31 | 18.00% |
| 2017-09-30 | 20.24% |
| 2017-06-30 | 20.24% |
| 2017-03-31 | 32.54% |
